Amgen quarterly revenue rises 6%, profit beats Street estimates

By Deena Beasley (Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs. The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects…

Read More

Gilead quarterly profit falls on COVID sales drop, legal settlement charge

By Michael Erman (Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs. The drugmaker raised its full-year revenue forecast, even as it trimmed its estimate for COVID antiviral Veklury due to lower pandemic-related hospitalizations….

Read More

UPS workers begin vote on tentative deal that averted US strike

By Lisa Baertlein and Aishwarya Nair (Reuters) – Thousands of UPS workers will start voting on their tentative contract agreement with the delivery giant on Thursday after local leaders of the International Brotherhood of Teamsters endorsed the union’s deal earlier this week. The tentative deal covering 340,000 Teamsters-represented workers at United Parcel Service averted a…

Read More

Monster Beverage sales miss estimates on lower customer spending

(Reuters) – Monster Beverage Corp missed Wall Street estimates for second-quarter sales on Thursday as higher cost of living weighed on demand for its pricier energy drinks and alcohol brands, sending its shares down 3.4% after the bell. Consumers have curbed non-essential spending as disposable incomes remain pressured by rising interest rates and higher food…

Read More